{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-163060","form_type":"8-K","ticker":"TEVA","cik":"0000818686","company_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","filed_at":"2023-06-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.351036+00:00","generated_at":"2026-06-14T05:26:08.003769+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"litigation","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Teva concludes nationwide opioids settlement up to $4.25B; resolves all 50 states and >99% subdivisions","bullets":["Teva will pay up to $4.25B over 13 years, including $1.2B of generic Narcan (or $240M cash) to participating states and subdivisions.","Separate settlement with Nevada for $193M over 20 years, averting trial scheduled for August 2023.","Settlement becomes effective August 7, 2023; first payments expected in H2 2023, with Narcan shipments already begun.","Teva has now resolved opioid claims with all 50 U.S. states and more than 99% of litigating subdivisions and special districts.","Agreement includes no admission of wrongdoing; company avoids further litigation uncertainty."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-163060","json":"https://secwatch.observer/filing/0001193125-23-163060.json","markdown":"https://secwatch.observer/filing/0001193125-23-163060.md","text":"https://secwatch.observer/filing/0001193125-23-163060.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/818686/000119312523163060/0001193125-23-163060-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/818686/000119312523163060/d461805d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T05:26:08.003769+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}